Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo — taking 2.5mg Mounjaro twice a week is not how the medicine is licensed or prescribed. Mounjaro (tirzepatide) is a once-weekly injection, and doubling up on doses in a single week (even at the starter strength) goes against the licensed dosing schedule set out in the Mounjaro Summary of Product Characteristics on the eMC. The 2.5mg dose is designed to be taken once every seven days to help your body adjust gradually; splitting or doubling it changes both the pharmacology and the safety profile of the medicine. These are prescription-only medicines, and the dosing schedule your prescriber sets is the one that matters for your safety.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide, the active ingredient in Mounjaro, has a half-life of roughly five days. That's the biological reason behind the once-weekly schedule: the medicine accumulates steadily in your system over the first few weeks, building toward a stable concentration. Dosing twice a week wouldn't double the effect, it would create an uneven peak-and-trough pattern that the medicine isn't designed for, and that hasn't been tested in clinical trials.
The NHS medicines page for tirzepatide is clear that Mounjaro is taken once a week, on the same day each week if possible. The instructions exist because the pharmacokinetics of the drug (how it moves through your body) are built around that interval. Changing the interval, even with the smallest pen, doesn't simply scale the dose down; it alters when the medicine peaks and how long it stays active.
If you're wondering whether two smaller injections might suit you better than one larger one, you can find a detailed look at taking Mounjaro as a half dose twice a week, which covers why that approach falls outside the licensed schedule and what the clinical reasoning is. The answer will almost certainly still be once weekly, but a prescriber can explain whether a different strength or a slower titration pace might work better for you.
The starter pen is a tolerability measure, not a therapeutic target. At 2.5mg, most people experience milder gastrointestinal effects than they would at higher doses, nausea, bloating and loose stools are the most common early complaints, and starting low gives the gut time to adapt. You're unlikely to see significant weight changes on 2.5mg alone, and that's expected; the dose is doing a different job.
After four weeks at 2.5mg, a prescriber will typically review progress before moving to 5mg, and you can read about what to expect at that next step on the Mounjaro 5mg guide. Each subsequent increase follows a similar four-week window. The titration schedule is individual, though: some people stay longer at a given dose if side effects are still settling, and a prescriber may decide not to increase if there's a clinical reason to hold. At nume, our clinical team reviews each patient before any dose change, it isn't automatic.
The takeaway here is that the 2.5mg dose has a specific, time-limited role in the treatment plan. If you've been asking yourself whether taking two 2.5mg doses of Mounjaro is an option, that page explains why it bypasses the safety logic built into the schedule rather than accelerating progress.
Doubling up at any strength increases exposure to tirzepatide beyond what the licensed dose provides. The most predictable consequence is a significant worsening of gastrointestinal side effects: nausea and vomiting that might have been mild on a single dose can become difficult to manage with two. Dehydration is a real risk if vomiting is severe, and that in turn can affect kidney function, something the NHS tirzepatide page flags as a reason to seek medical advice if you're unable to keep fluids down.
Beyond GI effects, there's a broader principle: taking a prescription medicine outside its licensed schedule (even with good intentions) means you're operating without the clinical evidence that supports the medicine's safety and efficacy. The SURMOUNT trials, which showed average weight reductions of around 20–21% at the highest doses over 72 weeks, were conducted strictly to once-weekly protocols. Those results don't transfer to a different dosing pattern.
If you're tempted to double up because you feel the medicine isn't working quickly enough, or because you missed a dose and are trying to compensate, those are conversations to have with your prescriber rather than decisions to make alone. There's a separate question about taking two doses of Mounjaro in a week that explores the missed-dose scenario in more detail.
Occasionally, people ask whether a prescriber could ever sanction something other than the standard once-weekly schedule. In practice, no, the licensed use of Mounjaro in the UK is once weekly, and prescribers work within that licence. What a prescriber can do is slow down titration (staying longer at each dose), adjust the injection day to fit your routine, or explore whether Mounjaro is the right treatment at all if you're finding it hard to tolerate.
On the practical side: if payday, a bank holiday or a planned trip is coming up and you're not sure whether to inject a day early or a day late, the safest approach is to check with your prescriber or pharmacist rather than adjust the frequency. The guide to taking 2.5mg Mounjaro covers what to do around scheduling in more detail.
Get medical help promptly if you experience severe, persistent stomach pain (particularly if it radiates to the back) with or without vomiting, as this can be a sign of pancreatitis, an infrequent but serious side effect that the MHRA has highlighted in safety guidance. For any concern about your treatment, you can also contact our team directly; aftercare is available seven days a week.
If you're finding the cost of ongoing treatment a factor in how you're managing your doses, the Mounjaro pricing page sets out what a legitimate private prescription actually includes, worth reading before drawing your own conclusions about value.
When you're ready to discuss your treatment plan with a prescriber, speaking to our prescribers is free and straightforward.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.